デフォルト表紙
市場調査レポート
商品コード
1426237

医薬品無菌検査の世界市場レポート 2024

Pharmaceutical Sterility Testing Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
医薬品無菌検査の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医薬品無菌検査の市場規模は、今後数年間で大幅に成長すると予想されます。 2028年には20.0%の年間複合成長率(CAGR)で31億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、バイオ医薬品の拡大、個別化医療の台頭、アウトソーシングへの傾向の高まり、品質保証の重視の高まり、パンデミックへの備えへの注目の高まりなど、いくつかの重要な要因と関連しています。この期間中に予想される主な動向には、迅速な微生物学的手法の採用、複合製品の開発、データの完全性とデジタル化への注力、オートメーションとロボット工学の統合、製薬業界における高度な分析技術の利用などが含まれます。

医薬品無菌検査市場の成長は、新薬の発売の急増と研究開発(R&D)への投資の増加に起因すると考えられます。医薬品製造における無菌状態の維持は、汚染を防止し、医薬品中に生存微生物が存在しないようにするために非常に重要です。特に、2022年3月に英国政府は、革新的な治療法とツールの研究開発イニシアチブに多額の3億4,700万米ドル(2億6,000万ポンド)を約束し、製薬情勢の進歩への取り組みを示しました。さらに、2021年12月のIQVIAレポートでは、今後5年間で特に特殊医薬品、ニッチ医薬品、オーファンドラッグにおいて新薬導入が大幅に増加し、それに伴い新製品への支出も大幅に増加すると予測しています。

医薬品無菌検査市場は、生物製剤の販売の拡大によって後押しされると予想されています。生物製剤には、ワクチン、血液成分、遺伝子治療など、生物由来の医薬品が含まれます。医薬品の無菌試験は、これらの生物製剤が患者に投与する前に微生物汚染がないことを確認する上で極めて重要な役割を果たします。たとえば、2023年にカナダ政府は、2021年の国内の生物製剤売上高が110億米ドルを超えたと報告し、医薬品無菌検査市場の推進において生物製剤売上の増加が影響力を持っていることを強調しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の医薬品無菌検査市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 機器
  • キットと試薬
  • サービス
  • 世界の医薬品無菌検査市場、サンプル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 無菌薬剤
  • 医療機器
  • 生物学的製剤と治療薬
  • 世界の医薬品無菌検査市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 社内
  • アウトソーシング
  • 世界の医薬品無菌検査市場、検査タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 無菌試験
  • バイオバーデン試験
  • 細菌エンドトキシン検査

第7章 地域および国の分析

  • 世界の医薬品無菌検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の医薬品無菌検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医薬品無菌検査市場の競合情勢
  • 医薬品無菌検査市場の企業プロファイル
    • Pacific Biolabs Inc.
    • STERIS Corporation
    • Boston Analytical Inc.
    • Gibraltar Laboratories Inc.
    • Sartorius AG

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r13259

Pharmaceutical sterility testing is a critical process designed to determine whether biological parenteral products intended for human use contain any extraneous, viable microorganisms. Ensuring the absence of contaminants is crucial for patient safety and the overall quality of medical products. Sterility testing guarantees that the products offered are appropriately free from harmful microorganisms.

Within pharmaceutical sterility testing, two primary types exist: in-house testing and outsourced testing. Various tests, including sterility testing, bioburden testing, and bacterial endotoxin testing, are conducted on sterile drugs, medical devices, biologics, and therapeutics. The bacterial endotoxin test, an in vitro assay, detects bacterial endotoxins by lysing blood cells from horseshoe crabs. Products utilized in this process include instruments, kits, reagents, and services.

The pharmaceutical sterility testing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical sterility testing market statistics, including pharmaceutical sterility testing industry global market size, regional shares, competitors with a pharmaceutical sterility testing market share, detailed pharmaceutical sterility testing market segments, pharmaceutical sterility testing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical sterility testing industry. This pharmaceutical sterility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical sterility testing market size has grown strongly in recent years. It will grow from $1.41 billion in 2023 to $1.54 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historical period can be attributed to several factors, including an increased demand for high-quality pharmaceutical products, a growing emphasis on the safety and efficacy of drugs, a rising demand for biologics and biosimilar drugs, the increasing prevalence of infectious diseases, and elevated investments in life science research.

The pharmaceutical sterility testing market size is expected to see strongly grown in the next few years. It will grow to $3.18 billion in 2028 at a compound annual growth rate (CAGR) of 20.0%. The anticipated growth in the forecast period is linked to several key factors, including the expansion of biopharmaceuticals, the rise of personalized medicine, a growing inclination towards outsourcing, a heightened emphasis on quality assurance, and an increased focus on pandemic preparedness. Major trends expected during this period encompass the adoption of rapid microbiological methods, the development of combination products, a focus on data integrity and digitalization, the integration of automation and robotics, as well as the utilization of advanced analytical techniques within the pharmaceutical industry.

Growth in the pharmaceutical sterility testing market is attributed to an upsurge in drug launches and increased investment in research and development (R&D). Maintaining sterility in drug manufacturing is crucial to prevent contamination and ensure the absence of viable microorganisms in medications. Notably, in March 2022, the UK government pledged a substantial $347 million (£260 million) towards R&D initiatives for innovative treatments and tools, signifying a commitment to advancing the pharmaceutical landscape. Additionally, IQVIA's report from December 2021 projects a significant rise in new drug introductions over the next five years, particularly in specialty, niche, and orphan drugs, accompanied by a substantial increase in spending on new products.

The pharmaceutical sterility testing market is expected to witness a boost driven by the escalating sales of biologics. Biologics encompass medicines derived from living organisms, including vaccines, blood components, and gene therapies. Sterility testing in pharmaceuticals plays a pivotal role in ensuring these biologics are devoid of microbial contamination prior to patient administration. For instance, in 2023, the Government of Canada reported biologics sales surpassing $11 billion in the country in 2021, underlining the influential role of rising biologics sales in propelling the pharmaceutical sterility testing market.

Key players in the pharmaceutical sterility testing market are introducing technologically advanced solutions, such as the sterility test isolator workstation (STIW), to address testing challenges and minimize erroneous results. The STIW, a specialized containment system, creates a sterile environment for conducting sterility tests on pharmaceutical products. For example, AUSTAR Group unveiled the Sterility Test Isolator Workstation (STIW) in March 2022 as part of their 'Standards' product range, featuring UDAF and TURB models. This barrier isolator technology significantly reduces false positives, fostering confidence in lab results while lowering operational costs. Designed for secure sterility testing, the STIW ensures protection against contamination, adhering to stringent guidelines. Its integrated bio-decontamination system expedites processing within 30 minutes, optimizing workflow efficiency for operators.

Major companies operating in the pharmaceutical sterility testing market include Pacific Biolabs Inc., STERIS Corporation, Boston Analytical Inc., Gibraltar Laboratories Inc., Sartorius AG, Solvias AG, SGS S.A., Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., bioMerieux Inc., Merck KGaA, WuXi AppTec, Sotera Health LLC, Dynalabs LLC, Infinity Laboratories, Eurofins Scientific SE, Avomeen Analytical Services, Microbac Laboratories Inc., Analytical Lab Group LLC, North American Science Associates Inc., Medical Device Testing Services Inc., Microtest Laboratories Inc., BioScreen Testing Services Inc., Microchem Laboratory Inc., Bactolac Pharmaceutical Inc., Micro Quality Labs Inc., Boston Microfluidics Inc., BioPharma Services Inc., Microbiology Research Associates, BioScience Laboratories Inc.

North America was the largest region in the pharmaceutical sterility testing market in 2023. The Middle East is expected to be the fastest-growing region in the global pharmaceutical sterility testing market share during the forecast period. The regions covered in the pharmaceutical sterility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the pharmaceutical sterility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharmaceutical sterility testing market includes revenues earned by entities by membrane filtration, direct transfer (product immersion), and product flush. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Sterility Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical sterility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical sterility testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical sterility testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Sample: Sterile Drugs; Medical Devices; Biologics and Therapeutics
  • 2) By Product Type: Instruments; Kits and Reagents; Services
  • 3) By Type: In- house; Outsourcing
  • 4) By Test Type: Sterility Testing; Bioburden Testing; Bacterial Endotoxin Testing
  • 5) By End- User: Compounding Pharmacies; Medical Devices Companies; Pharmaceutical Companies
  • Companies Mentioned: Pacific Biolabs Inc.; STERIS Corporation; Boston Analytical Inc.; Gibraltar Laboratories Inc.; Sartorius AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Sterility Testing Market Characteristics

3. Pharmaceutical Sterility Testing Market Trends And Strategies

4. Pharmaceutical Sterility Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Pharmaceutical Sterility Testing Market Size and Growth

  • 5.1. Global Pharmaceutical Sterility Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmaceutical Sterility Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmaceutical Sterility Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Sterility Testing Market Segmentation

  • 6.1. Global Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Kits and Reagents
  • Services
  • 6.2. Global Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sterile Drugs
  • Medical Devices
  • Biologics and Therapeutics
  • 6.3. Global Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In- house
  • Outsourcing
  • 6.4. Global Pharmaceutical Sterility Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sterility Testing
  • Bioburden Testing
  • Bacterial Endotoxin Testing

7. Pharmaceutical Sterility Testing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Sterility Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmaceutical Sterility Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Sterility Testing Market

  • 8.1. Asia-Pacific Pharmaceutical Sterility Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Sterility Testing Market

  • 9.1. China Pharmaceutical Sterility Testing Market Overview
  • 9.2. China Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Sterility Testing Market

  • 10.1. India Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Sterility Testing Market

  • 11.1. Japan Pharmaceutical Sterility Testing Market Overview
  • 11.2. Japan Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Sterility Testing Market

  • 12.1. Australia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Sterility Testing Market

  • 13.1. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Sterility Testing Market

  • 14.1. South Korea Pharmaceutical Sterility Testing Market Overview
  • 14.2. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Sterility Testing Market

  • 15.1. Western Europe Pharmaceutical Sterility Testing Market Overview
  • 15.2. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Sterility Testing Market

  • 16.1. UK Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Sterility Testing Market

  • 17.1. Germany Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Sterility Testing Market

  • 18.1. France Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Sterility Testing Market

  • 19.1. Italy Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Sterility Testing Market

  • 20.1. Spain Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Sterility Testing Market

  • 21.1. Eastern Europe Pharmaceutical Sterility Testing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Sterility Testing Market

  • 22.1. Russia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Sterility Testing Market

  • 23.1. North America Pharmaceutical Sterility Testing Market Overview
  • 23.2. North America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Sterility Testing Market

  • 24.1. USA Pharmaceutical Sterility Testing Market Overview
  • 24.2. USA Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Sterility Testing Market

  • 25.1. Canada Pharmaceutical Sterility Testing Market Overview
  • 25.2. Canada Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Sterility Testing Market

  • 26.1. South America Pharmaceutical Sterility Testing Market Overview
  • 26.2. South America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Sterility Testing Market

  • 27.1. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Sterility Testing Market

  • 28.1. Middle East Pharmaceutical Sterility Testing Market Overview
  • 28.2. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Sterility Testing Market

  • 29.1. Africa Pharmaceutical Sterility Testing Market Overview
  • 29.2. Africa Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Sterility Testing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Sterility Testing Market Competitive Landscape
  • 30.2. Pharmaceutical Sterility Testing Market Company Profiles
    • 30.2.1. Pacific Biolabs Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. STERIS Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boston Analytical Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Gibraltar Laboratories Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sartorius AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Pharmaceutical Sterility Testing Market Competitive Benchmarking

32. Global Pharmaceutical Sterility Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Sterility Testing Market

34. Pharmaceutical Sterility Testing Market Future Outlook and Potential Analysis

  • 34.1 Pharmaceutical Sterility Testing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Pharmaceutical Sterility Testing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Pharmaceutical Sterility Testing Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer